164 related articles for article (PubMed ID: 8905740)
1. Subacute toluene exposure increases DA dysfunction in the 6-OH dopamine lesioned nigrostriatal dopaminergic system of the rat.
Cintra A; Andbjer B; Finnman UB; Hagman M; Agnati LF; Höglund G; Fuxe K
Neurosci Lett; 1996 Oct; 217(1):61-5. PubMed ID: 8905740
[TBL] [Abstract][Full Text] [Related]
2. Subchronic toluene exposure in low concentrations produces signs of reduced dysfunction in the 6-hydroxydopamine lesioned nigrostriatal dopaminergic system of the rat.
Cintra A; Aguirre JA; Andbjer B; Finnman UB; Hagman M; Agnati LF; Höglund C; Möller A; Fuxe K
Neurosci Lett; 1999 Oct; 274(1):5-8. PubMed ID: 10530506
[TBL] [Abstract][Full Text] [Related]
3. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine.
Dluzen D
Brain Res; 1997 Sep; 767(2):340-4. PubMed ID: 9367266
[TBL] [Abstract][Full Text] [Related]
4. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
5. Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra.
Costa G; Abin-Carriquiry JA; Dajas F
Brain Res; 2001 Jan; 888(2):336-342. PubMed ID: 11150495
[TBL] [Abstract][Full Text] [Related]
6. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
Xu K; Dluzen DE
J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
[TBL] [Abstract][Full Text] [Related]
7. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G
Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway.
Andrés ME; Gysling K; Bustos G
Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143
[TBL] [Abstract][Full Text] [Related]
9. Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats.
Lindner MD; Cain CK; Plone MA; Frydel BR; Blaney TJ; Emerich DF; Hoane MR
Behav Brain Res; 1999 Jul; 102(1-2):1-16. PubMed ID: 10403011
[TBL] [Abstract][Full Text] [Related]
10. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y; Yoshimura R; Nakai K; Itakura T
Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
13. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
Thiruchelvam M; Richfield EK; Baggs RB; Tank AW; Cory-Slechta DA
J Neurosci; 2000 Dec; 20(24):9207-14. PubMed ID: 11124998
[TBL] [Abstract][Full Text] [Related]
14. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
Sivam SP
Brain Res; 1989 Oct; 500(1-2):119-30. PubMed ID: 2481560
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
[TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Agrawal AK
Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
[TBL] [Abstract][Full Text] [Related]
17. Effects of intranigral administration of dopamine agonists and antagonists and baclofen on concentrations of dopac and dopamine in the striatum and substantia nigra of the rat.
Wuerthele SM; Friedle NM; Moore KE
J Neural Transm; 1979; 45(2):117-27. PubMed ID: 469523
[TBL] [Abstract][Full Text] [Related]
18. Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease.
Lin L; Meng T; Liu T; Zheng Z
Life Sci; 2013 Mar; 92(4-5):311-6. PubMed ID: 23333823
[TBL] [Abstract][Full Text] [Related]
19. Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats.
Espino A; Cutillas B; Tortosa A; Ferrer I; Bartrons R; Ambrosio S
Brain Res; 1995 Oct; 695(2):151-7. PubMed ID: 8556325
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
Matsuura K; Makino H; Ogawa N
Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]